• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Proc Natl Acad Sci U S A . Syrian Hamsters as a Small Animal Model for SARS-CoV-2 Infection and Countermeasure Development

tetano

Editor, Senior Moderator
Proc Natl Acad Sci U S A


. 2020 Jun 22;202009799.
doi: 10.1073/pnas.2009799117. Online ahead of print.
Syrian Hamsters as a Small Animal Model for SARS-CoV-2 Infection and Countermeasure Development


Masaki Imai[SUP] 1 [/SUP], Kiyoko Iwatsuki-Horimoto[SUP] 1 [/SUP], Masato Hatta[SUP] 2 [/SUP], Samantha Loeber[SUP] 3 [/SUP], Peter J Halfmann[SUP] 2 [/SUP], Noriko Nakajima[SUP] 4 [/SUP], Tokiko Watanabe[SUP] 1 [/SUP], Michiko Ujie[SUP] 1 [/SUP], Kenta Takahashi[SUP] 4 [/SUP], Mutsumi Ito[SUP] 1 [/SUP], Shinya Yamada[SUP] 1 [/SUP], Shufang Fan[SUP] 2 [/SUP], Shiho Chiba[SUP] 2 [/SUP], Makoto Kuroda[SUP] 2 [/SUP], Lizheng Guan[SUP] 2 [/SUP], Kosuke Takada[SUP] 1 [/SUP], Tammy Armbrust[SUP] 2 [/SUP], Aaron Balogh[SUP] 2 [/SUP], Yuri Furusawa[SUP] 1 [/SUP], Moe Okuda[SUP] 1 [/SUP], Hiroshi Ueki[SUP] 1 [/SUP], Atsuhiro Yasuhara[SUP] 1 [/SUP], Yuko Sakai-Tagawa[SUP] 1 [/SUP], Tiago J S Lopes[SUP] 1 2 [/SUP], Maki Kiso[SUP] 1 [/SUP], Seiya Yamayoshi[SUP] 1 [/SUP], Noriko Kinoshita[SUP] 5 [/SUP], Norio Ohmagari[SUP] 5 [/SUP], Shin-Ichiro Hattori[SUP] 5 [/SUP], Makoto Takeda[SUP] 6 [/SUP], Hiroaki Mitsuya[SUP] 5 [/SUP], Florian Krammer[SUP] 7 [/SUP], Tadaki Suzuki[SUP] 4 [/SUP], Yoshihiro Kawaoka[SUP] 8 2 9 [/SUP]



Affiliations

Abstract

At the end of 2019, a novel coronavirus (severe acute respiratory syndrome coronavirus 2; SARS-CoV-2) was detected in Wuhan, China, that spread rapidly around the world, with severe consequences for human health and the global economy. Here, we assessed the replicative ability and pathogenesis of SARS-CoV-2 isolates in Syrian hamsters. SARS-CoV-2 isolates replicated efficiently in the lungs of hamsters, causing severe pathological lung lesions following intranasal infection. In addition, microcomputed tomographic imaging revealed severe lung injury that shared characteristics with SARS-CoV-2-infected human lung, including severe, bilateral, peripherally distributed, multilobular ground glass opacity, and regions of lung consolidation. SARS-CoV-2-infected hamsters mounted neutralizing antibody responses and were protected against subsequent rechallenge with SARS-CoV-2. Moreover, passive transfer of convalescent serum to na?ve hamsters efficiently suppressed the replication of the virus in the lungs even when the serum was administrated 2 d postinfection of the serum-treated hamsters. Collectively, these findings demonstrate that this Syrian hamster model will be useful for understanding SARS-CoV-2 pathogenesis and testing vaccines and antiviral drugs.

Keywords: SARS-CoV-2; Syrian hamsters; countermeasure; infection.
 
Back
Top